Role of 3 {u036C} {u0369} , 4 {u036D} {u036A} & 5 {u036D} {u036A} line chemotherapy in metastatic breast cancer : Treatment outcome and toxicity in nemrock between 2005 and 2010 /
Mohamed osman Mohamed Elhasan
Role of 3 , 4 & 5 line chemotherapy in metastatic breast cancer : Treatment outcome and toxicity in nemrock between 2005 and 2010 / دور خط العلاج الكيماوى الثالث والرابع والخامس فى علاج حالات سرطان الثدى المنتشر : نتائج العلاج والاعراض الجانبية بمركز قصر العينى لعلاج الأورام والطب النووى فى الفترة من 2005 - 2010 : دراسة تحليلية إرتجاعية Mohamed osman Mohamed Elhasan ; Supervised Mohamed Ali Morsi Abdien , Mona Ahmed Aboulenein , Wesam Elsharief - Cairo : Mohamed osman Mohamed Elhasan , 2012 - 84Leaves : charts ; 30cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology ( Clinical )
The aim of this study was to determine the benefit of chemotherapy beyond the second line in patients with metastatic breast cancer ; then , if a benefit was established , to identify patients who better benefit from the treatment . A total of 420 female patients with metastatic breast cancer were diagnosed in NEMROCK between 2005 and 2010 of whom orignally 52 female patients , later reduced to 24 female patients , and further reduced to 9 female patients received a third , fourth and fifth lines of chemotherapy , respectively
Chemotherapy 3 , 4 & 5 line Metastatic breast cancer Treatment outcome and toxicity in nemrock
Role of 3 , 4 & 5 line chemotherapy in metastatic breast cancer : Treatment outcome and toxicity in nemrock between 2005 and 2010 / دور خط العلاج الكيماوى الثالث والرابع والخامس فى علاج حالات سرطان الثدى المنتشر : نتائج العلاج والاعراض الجانبية بمركز قصر العينى لعلاج الأورام والطب النووى فى الفترة من 2005 - 2010 : دراسة تحليلية إرتجاعية Mohamed osman Mohamed Elhasan ; Supervised Mohamed Ali Morsi Abdien , Mona Ahmed Aboulenein , Wesam Elsharief - Cairo : Mohamed osman Mohamed Elhasan , 2012 - 84Leaves : charts ; 30cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology ( Clinical )
The aim of this study was to determine the benefit of chemotherapy beyond the second line in patients with metastatic breast cancer ; then , if a benefit was established , to identify patients who better benefit from the treatment . A total of 420 female patients with metastatic breast cancer were diagnosed in NEMROCK between 2005 and 2010 of whom orignally 52 female patients , later reduced to 24 female patients , and further reduced to 9 female patients received a third , fourth and fifth lines of chemotherapy , respectively
Chemotherapy 3 , 4 & 5 line Metastatic breast cancer Treatment outcome and toxicity in nemrock